Vimarsana
Biggest News Aggregation in the World

Page 2 - Statements This News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Statements This. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Statements This Today - Breaking & Trending Today

Diebold Nixdorf Incorporated : Investor Update Call August 2023 - Vimarsana News

Diebold Nixdorf Incorporated : Investor Update Call August 2023

- -Excluding the use of cash for the legal settlement related to the impaired cloud-based ERP implementation fees 5.0 5.6 5.6 - -Capital expenditures Capitalized software development Free... -Today at 07:49 am- MarketScreener

Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit - Vimarsana News

Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit

/PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC), and its gastroenterology business Salix Pharmaceuticals, today announced that, consistent with...

Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit - Vimarsana News

Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit

LAVAL, Quebec, Aug. 10, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC), and its gastroenterology business Salix Pharmaceuticals...

Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit - Vimarsana News

Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit

/PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC), and its gastroenterology business Salix Pharmaceuticals, today announced that, consistent with...

MannKind Corporation Announces Agreement to Acquire V-Go® Insulin Delivery Device From Zealand ... - Vimarsana News

MannKind Corporation Announces Agreement to Acquire V-Go® Insulin Delivery Device From Zealand ...

The once-daily insulin delivery device strengthens MannKind’s commitment to offering innovative mealtime diabetes solutions